Introduction:
Artificial intelligence is rapidly transforming oncology, evolving from image interpretation and pathology analysis to supporting complex clinical decision-making. This perspective argues that AI should enhance the capabilities of oncologists rather than replace their expertise.
Why was this article needed?
As AI becomes increasingly integrated into cancer care, there is growing debate over whether it should substitute physicians or function as a tool that augments clinical judgment. The authors advocate for a physician-centered model of AI adoption.
What did the article show?
- The authors distinguish physician-substituting AI from physician-complementing AI, favoring the latter approach.
- AI can reduce administrative burden through ambient documentation and automated electronic medical record workflows.
- AI can synthesize vast clinical, genomic, laboratory, and real-world data beyond human cognitive capacity.
- Decision-support AI may help oncologists personalize treatment by integrating multiple patient-specific variables.
- AI can incorporate patient preferences, quality-of-life goals, and comorbidities into therapeutic decision-making.
- Rather than replacing oncologists, AI enables clinicians to spend more time on patient communication, empathy, and shared decision-making.
- The future of precision oncology will depend on close collaboration between physician expertise and AI-driven intelligence.
Clinical Impact:
Physician-complementing AI has the potential to improve clinical efficiency, personalize treatment decisions, and support evidence-based oncology while preserving the essential role of physician judgment and the doctor–patient relationship.
Take-Home Message:
The greatest value of AI in oncology lies not in replacing physicians but in amplifying their expertise. By combining human clinical judgment with AI-powered decision support, cancer care can become more precise, efficient, and patient-centered.